P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON-BODY DELIVERY SYSTEM IN COMBINATION WITH POMALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: INTERIM PHASE 1B STUDY RESULTS

Detalles Bibliográficos
Autores principales: Quach, H., Parmar, G., Ocio, E. M., Prince, H. M., Oriol, A., Tsukada, N., Sunami, K., Bories, P., Karanes, C., Madan, S., Semiond, D., Inchauspe, M., Macé, S., Musholt, P. B., Suzan, F., Moreau, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428975/
http://dx.doi.org/10.1097/01.HS9.0000846648.34152.68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428975/
http://dx.doi.org/10.1097/01.HS9.0000846648.34152.68

Ejemplares similares